Thermo Fisher aims to make next-gen sequencing more accessible to community hospitals
The biotechnology product development company announced the launch of its Ion Torrent Genexus System at the Association for Molecular Pathology's annual meeting.
The biotechnology product development company announced the launch of its Ion Torrent Genexus System at the Association for Molecular Pathology's annual meeting.
In an article published in the journal mAbs Monday, executives from Adimab alleged that MIT's Ram Sasisekharan copied prior monoclonal antibody research. Visterra, a company Sasisekharan founded that had been developing one of the antibodies, was acquired by Otsuka for $430M last year.
The company has raised more than $100 million since 2017 and plans to use the current funding to build a pipeline of RNA-targeting small molecules.
Brammer specializes in contract services for viral vector-based gene therapies. Panelists at a conference last week stressed the importance of manufacturing for gene therapy investors.
The Waltham, Massachusetts-based company will receive $100 million, in addition to potential undisclosed milestones and royalties.
This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision-making by operationalizing elevated awareness.
The company hopes to start IND-enabling studies and clinical trials next year of orally available drugs in a class currently dominated by injected monoclonal antibodies.
Waltham, Massachusetts-based Fresenius Medical Care North America has agreed to pay $3.5 million to settle allegations of five HIPAA violations that occurred between February 23, 2012 and July 18, 2012.
The second annual Trinity Drug Index was published this week, sharing some valuable lessons on the success and failure of the 41 drugs approved back in 2014.
It's a sign of the times: PerkinElmer has acquired Euroimmun, a diagnostics company with a strong market presence in China and other emerging markets.
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.
The king of life science acquisitions has struck again. Thermo Fisher Scientific has announced plans to acquire Patheon, a Durham, North Carolina-based contract development and manufacturing organization with 9,000 employees worldwide.
The investigation into potential fraud could put the brakes on the planned multibillion-dollar acquisition of Alere by Abbott Laboratories.
Boston-area startup Akeso Biomedical is developing an iron-based compound to prevent foodborne illnesses, treat chronic wounds, and serve as bioscaffolding. The nascent device company just raised a small equity round of $225,000. It’s led by Simon Williams, the former president of biomaterials maker Tepha; the primary Fe3C technology is licensed from the University of Nottingham. Its […]